Medpace Holdings, Inc.
MEDP· Nasdaq
Released Jul 24, 2023, after the close
10-Q filed Jul 25, 2023, 25 days after period end · 0001668397-23-000043
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $460.87M | $351.21M | $278.29M | $205.00M |
| Net Income | $61.07M | $49.36M | $39.93M | $24.10M |
| EPS Diluted |
Medpace Holdings, Inc. · CIK 1668397 · Engraved from SEC EDGAR
| $1.93 |
| $1.46 |
| $1.06 |
| $0.64 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.